ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,885, issued on June 16, was assigned to Novartis AG (Basel, Switzerland).
"Polyomavirus neutralizing antibodies" was invented by Johanna Abend (Emeryville, Calif.), Vanessa Cornacchione (Basel, Switzerland), John Michael Lindner (Basel, Switzerland) and Elisabetta Traggiai (Basel, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to anti-polyomavirus antibodies, antibody fragments, and their uses for the prevention and treatment of BK or JC virus infection and associated diseases."
The patent was filed on Aug. 23, 2022, under Application No. 17/821,558.
*For further information, including images, charts and t...